How Automation Can Deliver the Holy Grail in Safety: Achieve Productivity, Compliance, and Quality
This Solution Provider Webinar is brought to you by DIA in cooperation with
The pharmacovigilance landscape is evolving substantially with the changing regulatory environment and compliance requirements. With the increase in the number of drugs being approved by major regulatory authorities globally, and increased awareness, social media connectivity, and media scrutiny, pharmaceutical companies would be required to conduct surveillance of drug-related adverse events more efficiently than ever.
This webinar will detail how organizations can counter these challenges and become more sophisticated in their drug-related adverse event reporting by adopting state-of-the-art cognitive computing processes into their existing pharmacovigilance management systems. It will address how cognitive computing technologies can automate a multitude of tasks in pharmacovigilance, thereby significantly increasing productivity, reducing adverse event case-processing time and reducing overall expense, and improving compliance.
Continuing Education Credits are not available for this event.
- Scope of automation in pharmacovigilance
- Application of cognitive computing technologies in case processing, including data entry, medical review, and literature surveillance
- How pharmacovigilance systems can help achieve compliance with changing regulations
- Understanding the expected productivity gains with the adoption of newer technologies in pharmacovigilance
- Quality of case processing can be much better using cognitive computing and robotic process automation
Who should attend?
- US and Europe region
- Primarily for business users QPPVs, Other business users. IT representatives may get some useful inputs. Pharma companies (Drugs, Devices, vaccines and Cosmetics)
- Describe the role of automation in the day-to-day pharmacovigilance activities
- Evaluate the impact of automation in conducting case processing tasks
- Describe how automated technologies can enable better compliance with the regulations than the traditional pharmacovigilance systems